DI NICOLANTONIO, Federica

DI NICOLANTONIO, Federica  

ONCOLOGIA  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autore(i) File
Abstract 1163: Microenvironment targets in KRAS-mutated metastatic colorectal cancer 2014 Marchio, Serena; Bartolini, Alice; Cardaci, Sabrina; Soster, Marco; Corti, Giorgio; Lamba, Simona; Bussolino, Federico; Cora', Davide; Di Nicolantonio, Federica
Acquired Resistance to Anti EGFR Therapy in Colorectal Cancer and Paracrine Protection by KRAS Mutated Cells 2012 Hobor S; Misale S; Crowley E; Scala E; Zanon C; Di Nicolantonio F; Bardelli A
BRAF V600E confers resistance to cetuximab or panitumumab metastatic colorectal cancer 2008 Di Nicolantonio F; Martini M; Molinari F; Bianchi AS; Arena S; Saletti P; Mazzucchelli L; Frattini M; Siena S; Bardelli A
EMERGENCE OF KRAS MUTATIONS AND ACQUIRED RESISTANCE TO ANTI EGFR THERAPY IN COLORECTAL CANCER 2012 Misale S; Yaeger R; Hobor S; Scala E; Janakiraman M; Liska D; Valtorta E; Schiavo R; Buscarino M; Siravergna G; Bencardino K; Cercek A; Chen C; Veronese S; Zanon C; Sartore-Bianchi A; Gambacorta M; Gallicchio M; Vakiani E; Boscaro V; Medico E; Weiser M; Siena S; di Nicolantonio F; Solit D; Bardelli A
Fibroblast Growth Factor Receptor (FGFR)3 sustains acquired resistance to trastuzumab in gastric cancer patients 2015 Piro, Geny; Carbone, Carmine; Cataldo, Ivana; Di Nicolantonio, Federica; Giacopuzzi, Simone; Boschi, Federico; Zanotto, Marco; Merz, Valeria; Sbarbati, Andrea; De Manzoni, Giovanni; Scarpa, Aldo; Tortora, Giampaolo; Melisi, Davide
Isogenic K-Ras mutant cancer cells: A novel platform for drug profiling 2011 Goodall J; Hunt J; Chen Z; Di Nicolantonio F; Gallicchio M; Lamba S; Bardelli A; Mahoney C; Astley H; Torrance C; Grimshaw K
Knock in of cancer mutations in human cells predicts pharmacologicalresponse to targeted therapies 2011 Valentina Boscaro; Davide Zecchin; Federica Di Nicolantonio; Alberto Bardelli; Margherita Gallicchio
Knock-in of oncogenic mutations in human somatic cells as a tool to identify genoselective compounds 2007 Federica Di Nicolantonio; Sabrina Arena; Margherita Gallicchio; Miriam Martini; Davide Zecchin; Simona Flonta; Giulia Stella; Giovanni Appendino; Roberto Fantozzi; Enzo Medico; Alberto Bardelli
RAF Inhibitors 2011 Di Nicolantonio F
Rapid up-regulation of cyclo-oxygenase 2 (COX-2) by 5-fluoruracil (5-FU) in human solid tumours 2004 Di Nicolantonio F; Mercer S; Knight LA; Gabriel FG; Whitehouse PA; Sharma S; Fernando A; Bhandari P; Somers SS; Toh SK; Cree IA
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 2019 Amodio, V; Grmano, G; Barault, L; Lamba, S; Rospo, G; Magri, A; Maione, F; Crisafulli, G; Cancelliere, C; Lerda, G; Bartolini, A; Siravegna, G; Mussolin, B; Frappolli, R; Montone, M; Randon, G; de Braud, F; Angelozzi, NA; Marsoni, S; D'Incalci, M; Orlandi, A; Giraudo, E; Satore-Bianchi, A; Siena, S; Pietrantonio, F; Di Nicolantonio, F; Bardelli, A
Unveiling of BRAF V600E Mutant Cells Sensitivity to Proteasome Inhibitors Using an Isogenic Cell Based Screening 2013 V. Boscaro; D. Zecchin; A. Bardelli; F. Di Nicolantonio; M. Gallicchio